Pär Nordell

586 total citations
22 papers, 475 citations indexed

About

Pär Nordell is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Pär Nordell has authored 22 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Pär Nordell's work include DNA and Nucleic Acid Chemistry (10 papers), Metal complexes synthesis and properties (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Pär Nordell is often cited by papers focused on DNA and Nucleic Acid Chemistry (10 papers), Metal complexes synthesis and properties (8 papers) and Drug Transport and Resistance Mechanisms (6 papers). Pär Nordell collaborates with scholars based in Sweden, United Kingdom and United States. Pär Nordell's co-authors include Per Lincoln, Bengt Nordén, Fredrik Westerlund, L. Marcus Wilhelmsson, Ken Grime, Johanna Andersson, Eimer Tuite, Maria Abrahamsson, Louise Fornander and Gustav Holmgren and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Pär Nordell

21 papers receiving 460 citations

Peers

Countries citing papers authored by Pär Nordell

Since Specialization

Citations

This map shows the geographic impact of Pär Nordell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Nordell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Nordell more than expected).

Fields of papers citing papers by Pär Nordell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Nordell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Nordell. The network helps show where Pär Nordell may publish in the future.

Co-authorship network of co-authors of Pär Nordell

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Nordell. A scholar is included among the top collaborators of Pär Nordell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Nordell. Pär Nordell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and Validation 2025 ·The AAPS Journal ·(unknown), Pär Nordell, Christine Ahlström, Hans Lennernäs, Erik Sjögren	0
2	Abstract 4357315: AZD0233: a CX3CR1 Modulator that Regulates Immune Cells, Improves Cardiac Function, and Alleviates Myocardial Fibrosis in a Mouse Model of Dilated Cardiomyopathy 2025 ·Circulation ·Liang Guo, Margareta Behrendt, Weike Bao, (unknown), (unknown), Gustav Holmgren, Nils-Olov Hermansson, (unknown), Aruni Jha, Carl Whatling, Erik Michaëlsson, Pär Nordell, Karolina Nilsson, Magnus Söderberg, Gábor Földes, (unknown), Karin Jennbacken, Christine Ahlström	1
3	Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists 2024 ·Pharmaceutics ·Alessandro Boianelli, Pär Nordell, (unknown), (unknown), David C. Hornigold, Rasmus Jansson‐Löfmark, Monika Sundqvist	2
4	Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Anna Vildhede, Pär Nordell, Christine Ahlström, (unknown), Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren	4
5	Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK 2022 ·ACS Medicinal Chemistry Letters ·Frederick W. Goldberg, Attilla Ting, David T. Beattie, Gillian M. Lamont, Charlene Fallan, M. Raymond V. Finlay, Beth Williamson, Marianne Schimpl, Alexander R. Harmer, (unknown), Pär Nordell, Anna Cronin, Mercedes Vázquez–Chantada, Derek Barratt, Antonio Ramos‐Montoya, Elaine Cadogan, Barry R. Davies	7
6	P245 - Investigation of renal drug secretion in a kidney-on-a-chip model 2020 ·Drug Metabolism and Pharmacokinetics ·Simone H. Stahl, Pär Nordell, Tom T.G. Nieskens, Katherine S. Fenner, Pedro Caetano-Pinto	1
7	Intrinsic Clearance Assay Incubational Binding: A Method Comparison 2017 ·Drug Metabolism and Disposition ·(unknown), (unknown), Fredrik Bergström, Pär Nordell, Ken Grime	16
8	Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice 2017 ·International Journal of Pharmaceutics ·Kalle Sigfridsson, Pia Skantze, Urban Skantze, (unknown), Lars Löfgren, Pär Nordell, Erik Michaëlsson, Bård Smedsrød, (unknown), Kjetil Elvevold, Lennart Lindfors	22
9	An S‐warfarin and AZD1981 interaction:in vitroand clinical pilot data suggest the N‐deacetylated amino acid metabolite as the primary perpetrator 2016 ·British Journal of Clinical Pharmacology ·Ken Grime, Rikard Pehrson, Pär Nordell, Michael Gillen, (unknown), Timothy Mant, (unknown), (unknown), Barry Jones, Clive Brealey	3
10	Montelukast Disposition: No Indication of Transporter-Mediated Uptake in OATP2B1 and OATP1B1 Expressing HEK293 Cells 2015 ·Pharmaceutics ·(unknown), Pär Nordell, Britta Bonn, (unknown), (unknown), Constanze Hilgendorf, (unknown), Ken Grime	10
11	Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells 2013 ·Biochemical Pharmacology ·(unknown), Pär Nordell, Annika Asplund, (unknown), (unknown), Gustav Holmgren, L. S. P. Davidson, Gabriella Brolén, Josefina Edsbagge, Petter Björquist, Barbara Küppers-Munther, Tommy B. Andersson	77
12	Predicting Metabolic Clearance for Drugs That Are Actively Transported into Hepatocytes: Incubational Binding as a Consequence of in Vitro Hepatocyte Concentration Is a Key Factor 2013 ·Drug Metabolism and Disposition ·Pär Nordell, (unknown), (unknown), Ken Grime	10
13	Resolving the Distribution–Metabolism Interplay of Eight OATP Substrates in the Standard Clearance Assay with Suspended Human Cryopreserved Hepatocytes 2013 ·Molecular Pharmaceutics ·Pär Nordell, Susanne Winiwarter, Constanze Hilgendorf	15
14	Lifetime Heterogeneity of DNA-Bound dppz Complexes Originates from Distinct Intercalation Geometries Determined by Complex–Complex Interactions 2012 ·Inorganic Chemistry ·Johanna Andersson, Louise Fornander, Maria Abrahamsson, Eimer Tuite, Pär Nordell, Per Lincoln	42
15	Transition State of Rare Event Base Pair Opening Probed by Threading into Looped DNA 2011 ·ChemBioChem ·(unknown), Bengt Nordén, Per Lincoln, Pär Nordell	5
16	Supercoil-Accelerated DNA Threading Intercalation 2009 ·Biochemistry ·Pär Nordell, Erik T. Jansson, Per Lincoln	9
17	DNA Polymorphism as an Origin of Adenine-Thymine Tract Length-Dependent Threading Intercalation Rate 2008 ·Journal of the American Chemical Society ·Pär Nordell, Fredrik Westerlund, Anna Reymer, Afaf H. El‐Sagheer, Tom Brown, Bengt Nordén, Per Lincoln	29
18	Kinetic Recognition of AT‐Rich DNA by Ruthenium Complexes 2007 ·Angewandte Chemie International Edition ·Pär Nordell, Fredrik Westerlund, L. Marcus Wilhelmsson, Bengt Nordén, Per Lincoln	60
19	Kinetic Recognition of AT‐Rich DNA by Ruthenium Complexes 2007 ·Angewandte Chemie ·Pär Nordell, Fredrik Westerlund, L. Marcus Wilhelmsson, Bengt Nordén, Per Lincoln	18
20	Kinetic Characterization of an Extremely Slow DNA Binding Equilibrium 2007 ·The Journal of Physical Chemistry B ·Fredrik Westerlund, Pär Nordell, Bengt Nordén, Per Lincoln	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact